Form4insider filings, from the source

SEC Form 4 · accession 0001171843-19-001386

Anika Therapeutics, Inc. · ANIK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Joseph G Darling
Officer — President and CEO; Director · Director
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1$0.00Feb 26, 2019A63,000A——Common Stock63,00063,000D
Stock Option (Right to Buy)F3,F2,F4$61.47Feb 27, 2019A7,609A—Jan 24, 2028Common Stock7,6097,609D

Explanation of responses